Page results
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information.
-
Fiona Farrell works at the Sir William Gowers Unit, a specialist treatment centre for epilepsy and related disorders.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
UCLH and UCL are at the forefront of Women’s Health care and research – across areas including reproductive health, maternity, breast care, care for newborns, gynaecological care, and cancer.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
File results
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust
-
FOI/2022/0325 - Number of patients on the public RTT pathway
-
FOI/2022/0327 - Data Protection Officer job description
-
FOI/2022/0328 - Treatment for migraine
-
FOI/2022/0330 - Sleep and respiratory services
-
FOI/2022/0333 - Maternity care report
-
FOI/2022/0338 - X-ray reporting and interpretation of nasogastric tube placement
-
FOI/2022/0344 - Patient Administration System (PAS) used at Trust
-
FOI/2022/0345 - Contact details for Director of Estates and Facilities
-
FOI/2022/0346 - Renal cell carcinoma and melanoma treatments